NurExone Biologic reports Q2 results
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Our Buyer ETF Base Has Expanded: AB's Gunts
Julie Gunts, global head of ETFs at AllianceBernstein, joins Scarlet Fu and Eric Balchunas on "Bloomberg ETF IQ." (Source: Bloomberg)
Bessent pushes back on Druckenmiller critique of bond intervention
Bessent, at a G20 finance meeting, told CNBC he spoke with Stanley Druckenmiller after his critical op-ed was published and that their conversation went "fine."
Tesla’s stock is leading S&P 500 gainers as investors prepare for a Cybercab launch
The company is seemingly getting closer to rolling out a vehicle that comes without a steering wheel or pedals.
Eskom’s R30.3bn profit rebound faces its next test
Better pricing, new customers, the unbundling – and municipal debt, which is ‘no longer an Eskom risk but a country risk’: Eskom Group CEO Dan Marokane.
Broadcom Has Trailed the S&P 500 This Year. That Shouldn't Last Much Longer.
Broadcom is likely to close the gap and beat the S&P 500 this year.